Abbott, Alere Settle Watchdogs' Issues With $5.3B Deal
U.S. and Canadian antitrust regulators revealed Thursday that pharmaceutical giant Abbott Laboratories and diagnostic service provider Alere Inc. have settled the agencies' concerns over Abbott's $5.3 billion bid for Alere....To view the full article, register now.
Already a subscriber? Click here to view full article